Raymond James & Associates Elanco Animal Health Inc Transaction History
Raymond James & Associates
- $146 Billion
- Q1 2024
A detailed history of Raymond James & Associates transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Raymond James & Associates holds 1,212,473 shares of ELAN stock, worth $17.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,212,473
Previous 1,214,532
0.17%
Holding current value
$17.5 Million
Previous $18.1 Million
9.08%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding ELAN
# of Institutions
406Shares Held
473MCall Options Held
2.6MPut Options Held
916K-
Dodge & Cox San Francisco, CA83.8MShares$1.21 Billion0.84% of portfolio
-
Primecap Management CO Pasadena, CA52.9MShares$763 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.3MShares$711 Million0.02% of portfolio
-
Black Rock Inc. New York, NY26.6MShares$384 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD22.1MShares$319 Million0.04% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.84B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...